Audiometric evaluations should ideally be conducted before the initiation of cancer treatment to establish a baseline hearing level. Subsequent tests should be performed periodically during treatment and after its completion to monitor any changes in hearing ability. This allows healthcare providers to make informed decisions about modifying treatment plans if necessary.
